NDC 55289-633

Chlorzoxazone

Chlorzoxazone

Chlorzoxazone is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Pd-rx Pharmaceuticals, In. The primary component is Chlorzoxazone.

Product ID55289-633_7c341b25-cd06-1c4b-e053-2991aa0abb4c
NDC55289-633
Product TypeHuman Prescription Drug
Proprietary NameChlorzoxazone
Generic NameChlorzoxazone
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2011-08-22
Marketing CategoryANDA / ANDA
Application NumberANDA089859
Labeler NamePD-Rx Pharmaceuticals, In
Substance NameCHLORZOXAZONE
Active Ingredient Strength500 mg/1
Pharm ClassesCentrally-media
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 55289-633-10

10 TABLET in 1 BOTTLE, PLASTIC (55289-633-10)
Marketing Start Date2011-08-31
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 55289-633-28 [55289063328]

Chlorzoxazone TABLET
Marketing CategoryANDA
Application NumberANDA089859
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2011-08-31

NDC 55289-633-40 [55289063340]

Chlorzoxazone TABLET
Marketing CategoryANDA
Application NumberANDA089859
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2011-08-31

NDC 55289-633-10 [55289063310]

Chlorzoxazone TABLET
Marketing CategoryANDA
Application NumberANDA089859
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2011-08-31

NDC 55289-633-24 [55289063324]

Chlorzoxazone TABLET
Marketing CategoryANDA
Application NumberANDA089859
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2011-08-31

NDC 55289-633-20 [55289063320]

Chlorzoxazone TABLET
Marketing CategoryANDA
Application NumberANDA089859
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2011-08-31

NDC 55289-633-30 [55289063330]

Chlorzoxazone TABLET
Marketing CategoryANDA
Application NumberANDA089859
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2011-08-31

Drug Details

Active Ingredients

IngredientStrength
CHLORZOXAZONE500 mg/1

OpenFDA Data

SPL SET ID:8650d342-92df-48d7-9f3d-cdd6f6f4c0e7
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 197502
  • UPC Code
  • 0355289633204
  • Pharmacological Class

    • Centrally-mediated Muscle Relaxation [PE]
    • Muscle Relaxant [EPC]

    NDC Crossover Matching brand name "Chlorzoxazone" or generic name "Chlorzoxazone"

    NDCBrand NameGeneric Name
    0254-2005ChlorzoxazoneChlorzoxazone
    0254-2053ChlorzoxazoneChlorzoxazone
    0591-2520ChlorzoxazoneChlorzoxazone
    13811-717chlorzoxazonechlorzoxazone
    13811-718chlorzoxazonechlorzoxazone
    16571-725CHLORZOXAZONECHLORZOXAZONE
    16571-726CHLORZOXAZONECHLORZOXAZONE
    16571-727CHLORZOXAZONECHLORZOXAZONE
    21695-569ChlorzoxazoneChlorzoxazone
    24470-923CHLORZOXAZONECHLORZOXAZONE
    33261-021ChlorzoxazoneChlorzoxazone
    42254-076ChlorzoxazoneChlorzoxazone
    42494-425ChlorzoxazoneChlorzoxazone
    42494-426ChlorzoxazoneChlorzoxazone
    42494-427ChlorzoxazoneChlorzoxazone
    42494-428ChlorzoxazoneChlorzoxazone
    45865-434ChlorzoxazoneChlorzoxazone
    46672-117chlorzoxazonechlorzoxazone
    46672-118chlorzoxazonechlorzoxazone
    46672-860chlorzoxazonechlorzoxazone
    49999-044ChlorzoxazoneChlorzoxazone
    50090-0315ChlorzoxazoneChlorzoxazone
    50090-0316ChlorzoxazoneChlorzoxazone
    51862-338Chlorzoxazonechlorzoxazone
    51862-339Chlorzoxazonechlorzoxazone
    69499-330chlorzoxazonechlorzoxazone
    70518-0496ChlorzoxazoneChlorzoxazone
    53002-5760ChlorzoxazoneChlorzoxazone
    55045-1594ChlorzoxazoneChlorzoxazone
    55289-633ChlorzoxazoneChlorzoxazone
    61919-478CHLORZOXAZONECHLORZOXAZONE
    63187-317ChlorzoxazoneChlorzoxazone
    66267-055ChlorzoxazoneChlorzoxazone
    66336-663ChlorzoxazoneChlorzoxazone
    70518-2053ChlorzoxazoneChlorzoxazone
    69597-330chlorzoxazonechlorzoxazone
    70954-085ChlorzoxazoneChlorzoxazone
    73007-013ChlorzoxazoneChlorzoxazone
    51862-340ChlorzoxazoneChlorzoxazone
    72319-169CHLORZOXAZONECHLORZOXAZONE
    60760-479ChlorzoxazoneChlorzoxazone

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.